Sarah Mueller-Steiner

O4-06-05 Anti-amyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer’s disease

L. Mucke, L. Gan, E. Roberson, 2006, Alzheimer's & Dementia.

Interaction of receptor-activity-modifying protein1 with tubulin.

T. Kunz, H. Troxler, L. Ittner, 2007, Biochimica et Biophysica Acta.

SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling.

L. Mucke, L. Gan, Lin-Feng Chen, 2005, The Journal of biological chemistry.

SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling*

L. Mucke, L. Gan, Lin-Feng Chen, 2005, Journal of Biological Chemistry.

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease

E. Masliah, Manuel Buttini, R. Barbour, 2011, PloS one.

Biochemical and morphological consequences of human α‐synuclein expression in a mouse α‐synuclein null background

E. Richfield, Manuel Buttini, M. O'Neill, 2011, The European journal of neuroscience.

Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease

L. Gan, N. Devidze, Seo-hyun Cho, 2008, Neuron.

Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease

L. Mucke, L. Gan, E. Roberson, 2006, Neuron.